Lineage Cell Therapeutics, Inc. - COM (LCTX)

Historical Portfolio Holders from Q2 2019 to Q1 2024

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	93 M	$138 M	+$26.6 M	0	31.7 K	$1.48	112
2023 Q4	75.2 M	$82 M	-$20.4 K	981	3.6 K	$1.09	113
2023 Q3	75.5 M	$89.1 M	-$399 K	0	35.8 K	$1.18	102
2023 Q2	75.6 M	$107 M	+$8.58 M	705	7.19 K	$1.41	105
2023 Q1	69.7 M	$105 M	+$7.06 M	750	71.3 K	$1.50	114
2022 Q4	65.1 M	$76.1 M	+$642 K	1.76 K	19.3 K	$1.17	99
2022 Q3	64.5 M	$72.9 M	-$314 K	0	92 K	$1.13	86
2022 Q2	64.6 M	$102 M	-$10.3 M	17 K	255 K	$1.58	80
2022 Q1	72.8 M	$112 M	-$3.68 M	104 K	274 K	$1.54	97
2021 Q4	72.5 M	$178 M	-$3.16 M	225 K	1.13 M	$2.45	109
2021 Q3	73.3 M	$185 M	+$5.64 M	524 K	1.27 M	$2.52	104
2021 Q2	73.1 M	$208 M	+$35.6 M	424 K	529 K	$2.85	100
2021 Q1	60.2 M	$141 M	+$12.4 M	396 K	109 K	$2.35	88
2020 Q4	54.7 M	$96.2 M	+$3.09 M	47 K	904 K	$1.76	73
2020 Q3	53.4 M	$50 M	-$1.83 M		44 K	$0.94	63
2020 Q2	55.5 M	$48.3 M	-$6.85 M		46 K	$0.87	77
2020 Q1	63.8 M	$52.8 M	+$476 K		69 K	$0.83	77
2019 Q4	63.2 M	$56.2 M	-$1.2 M	0	0	$0.89	80
2019 Q3	64.4 M	$63.1 M	+$63 M	12 K	18 K	$0.98	78
2019 Q2	18 K	$20 K	+$20 K			$1.11	1